MBAI · Check-Cap Ltd
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Aug 13, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on Aug 13, 2026.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MBAI
this stock
Check-Cap Ltd
|
$9.05M | — | — | — | 2.0% |
|
TMO
Thermo Fisher Scientific Inc.
|
$230.05B | +3.6% | +14.5% | 33.5 | 1.3% |
|
DHR
Danaher Corp /De/
|
$147.09B | -9.6% | +8.5% | 37.1 | 1.2% |
|
NTRA
Natera, Inc.
|
$47.03B | +40.0% | -2.8% | — | 3.0% |
|
IQV
Iqvia Holdings Inc.
|
$43.12B | +14.6% | +41.6% | 32.1 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 0.1%
- Net QoQ
- +1.0K sh
- Top holder
- CITADEL ADVISORS LLC
Performance
Raw-price comparisons begin at the captured split on Aug 13, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MBAI | -18.8% | — | — | -0.8% | — |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | -18.3% | — | — | -0.1% | — |